Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease

BACKGROUND: Metabolic dysfunction–associated fatty liver disease (MAFLD), defined as fatty liver with overweight/obesity, type 2 diabetes, or metabolic abnormalities, is a newly proposed disease. However, it remains unclear whether the coexistence of MAFLD and chronic kidney disease (CKD) is a more...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamori, Daisuke, Tanaka, Marenao, Sato, Tatsuya, Endo, Keisuke, Mori, Kazuma, Mikami, Takuma, Hosaka, Itaru, Hanawa, Nagisa, Ohnishi, Hirofumi, Furuhashi, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382120/
https://www.ncbi.nlm.nih.gov/pubmed/37421273
http://dx.doi.org/10.1161/JAHA.123.030269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382120/
https://www.ncbi.nlm.nih.gov/pubmed/37421273
http://dx.doi.org/10.1161/JAHA.123.030269

Ejemplares similares